FGFR2 and cancer: The 864 mutated genes (410 in newly generated subclones; 454 in eliminated subclones) were enriched for annotations related to several cancer-related pathways, including “FGFR2 mutant receptor activation”, “RAC1 GTPase cycle”, “Signaling by MAPK mutants”, etc. (Fig. 4g).